Inorganic pyrophosphate generation and disposition in pathophysiology

American Journal of Physiology - Cell Physiology

Volumn 281, Issue 1 50-1, 2001, Pages

  Terkeltaub, Robert A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

alkaline phosphatase; ANK; Chondrocalcinosis; Hydroxyapatite; Inorganic pyrophosphatase; PC 1

Indexed keywords

ALKALINE PHOSPHATASE; AUTOTAXIN; CELL MEMBRANE PROTEIN; HYDROXYAPATITE; MEMBRANE PROTEIN; NUCLEOTIDE PYROPHOSPHATASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE NUCLEOTIDE PYROPHOSPHATASE; PHOSPHODIESTERASE NUCLEOTIDE PYROPHOSPHATASE 3; PLASMA CELL MEMBRANE GLYCOPROTEIN 1; PROTEIN ANK; PYROPHOSPHATE; UNCLASSIFIED DRUG;

ANKYLOSIS; CALCIFICATION; CARTILAGE CELL; CELL FUNCTION; CELL MEMBRANE TRANSPORT; CELL METABOLISM; CHONDROCALCINOSIS; CONNECTIVE TISSUE DISEASE; CRYSTALLIZATION; DEGRADATION; HUMAN; NONHUMAN; OSTEOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

EID: 0034813884     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.2001.281.1.c1     Document Type: Review

References (128)

1. Molecular biology of matrix vesicles
2. Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals
3. Lack of oxygen sensing by mitochondria in platelets
4. Developmental expression analysis of murine autotaxin (ATX)
5. BMP-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/2)
6. A pyrophosphate synthase gene: Molecular cloning and sequencing of the cDNA encoding the inorganic pyrophosphate synthase from Rhodospirillum rubrum
7. +-proton-pumping inorganic pyrophosphatase: A tightly membrane-bound family
8. Cytoplasmic inorganic pyrophosphatase
9. Phosphate is a specific signal for induction of osteopontin gene expression
10. i with actomyosin
11. Uptake by bone of pyrophosphate, diphosphonates and their technetium derivatives
12. ENPP3 (CD203c)
13. Mechanism of phosphorylation in the lumen of the Golgi apparatus. Translocation of adenosine 5′-triphosphate into Golgi vesicles from rat liver and mammary gland
14. Serum nucleotide pyrophosphohydrolase activity; elevated levels in osteoarthritis, calcium pyrophosphate crystal deposition disease, scleroderma, and fibromyalgia
15. Phosphocitrate as a potential therapeutic strategy for crystal deposition disease
16. Phosphocitrate blocks nitric oxide-induced calcification of cartilage and chondrocyte-derived apoptotic bodies
17. The primordial high energy compound: ATP or inorganic pyrophosphate?
18. Autotaxin is an exoenzyme possessing 5′-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities
19. Matrix mineralization in hypertrophic chondrocyte cultures. Beta glycerophosphate increases type X collagen messenger RNA and the specific activity of pp60c-src kinase
20. 3+ between pyrophosphate and transferrin. Probing the nature of an intermediate complex with stopped flow kinetics, rapid multimixing, and electron paramagnetic resonance spectroscopy
21. Protein phosphorylation by inorganic pyrophosphate in yeast mitochondria
22. 2+], and its role in the hormonal regulation of mitochondrial matrix volume
23. Inorganic pyrophosphate is located primarily in the mitochondria of the hepatocyte and increases in parallel with the decrease in light-scattering induced by gluconeogenic hormones, butyrate and ionophore A23187
24. 2+ and regulates the intramitochondrial volume and adenine nucleotide content
25. The decrease in serum bone-specific alkaline phosphatase predicts bone mineral density response to hormone replacement therapy in early postmenopausal women
26. A thermostable vacuolar-type membrane pyrophosphatase from the archaeon Pyrobaculum aerophilum: Implications for the origins of pyrophosphate-energized pumps
27. Cloning and expression profile of human inorganic pyrophosphatase
28. Alendronate mechanism of action: Geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
29. Inhibitors and promoters of stone formation
30. A review of the physiological and pharmacological effects of pyrophosphate and diphosphonates on bones and teeth
31. Inhibition of aortic calcification by means of pyrophosphate and polyphosphates
32. A superfamily of metalloenzymes unifies phosphopentomutase and cofactor-independent phosphoglycerate mutase with alkaline phosphatases and sulfatases
33. 32P]ATP
34. Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases
35. Ecto-enzymes: Physiology meets pathology
36. Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and nonlymphoid cells: Structure and function of the PC-1 family
37. Role of PC-1 in the etiology of insulin resistance
38. i metabolism and matrix synthesis
39. An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma
40. Guanylate cyclase from bovine rod outer segments: Solubilization, partial purification, and regulation by inorganic pyrophosphate
41. Basic calcium phosphate (apatite, octacalcium phosphate, tricalcium phosphate) crystal deposition diseases; calcinosis
42. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage
43. Role of the mouse ank gene in control of tissue calcification and arthritis
44. 2+ deposition by rat matrix vesicles: Is the membrane association of alkaline phosphatase essential for matrix vesicle-mediated calcium deposition?
45. Evidence of the presence of a specific ATPase responsible for ATP-initiated calcification by matrix vesicles isolated from cartilage and bone
46. Localisation of a gene for chondrocalcinosis to chromosome 5p
47. Focal expression of plasma cell membrane glycoprotein-1 (PC-1) is both a marker and potential direct promoter of calcification in knee meniscal chondrocalcinosis
48. Central role of plasma cell membrane glycoprotein-1 (PC-1) in the pathogenesis of meniscal CPPD deposition disease (CPPD-DD) of the knee
49. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization
50. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells
51. i production by plasma cell membrane glycoprotein-1 (PC-1) and B10 in chondrocytes
52. Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1
53. Diseases associated with calcium pyrophosphate deposition disease
54. i-binding properties of mitochondrial F1-ATPase
55. Expression and transcriptional regulation of the PD-Ia/autotaxin gene in neuroblastoma
56. Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage
57. Phosphocitrate prevents disease progression in murine progressive ankylosis
58. Structure, composition, and maturation of newly deposited calcium-phosphate crystals in chicken osteoblast cell structures
59. 2+ ions against fluoride inhibition
60. Effects of spermine and spermidine on the inorganic pyrophosphatase of Streptococcus faecalis. Interactions between polyamines and inorganic pyrophosphate
61. Biochemical characterization of the tartrate-resistant acid phosphatase of human spleen with leukemic reticuloendotheliosis as a pyrophosphatase
62. The human CILP gene: Exon/intron organization and chromosomal mapping
63. A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age
64. Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a proform including a nucleotide pyrophosphohydrolase
65. i-generating enzyme PC-1 in human chondrocytes
66. Transport of inorganic pyrophosphate across the spinach chloroplast envelope
67. Extracellular phosphate ions cause apoptosis of terminally differentiated epiphyseal chondrocytes
68. Inorganic pyrophosphate in mitochondrial metabolism
69. Exclusion of the gene for human cartilage intermediate layer protein in currently mapped calcium pyrophosphate deposition syndromes
70. Recombinant human and mouse purple acid phosphatases: Expression and characterization
71. Molecular cloning and expression of a porcine chondrocyte nucleotide pyrophosphohydrolase
72. A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles
73. Inorganic phosphate induces apoptosis of osteoblast-like cells in culture
74. Can biological calcification occur in the presence of pyrophosphate?
75. The glycosomal ATP-dependent phosphofructokinase of Trypanosoma brucei must have evolved from an ancestral pyrophosphate-dependent enzyme
76. Evidence in vitro for an enzymatic synthesis of phosphocitrate
77. Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway
78. Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL)
79. Inactivation of two mouse alkaline phosphatase genes and establishment of a mouse model of infantile hypophosphatasia
80. The influx of pyrophosphate ions into calvaria in vitro
81. Immunological cross-reactivity between proton-pumping inorganic pyrophosphatases of widely phylogenic separated species
82. Calcitonin simultaneously regulates both periosteal hyperostosis and trabecular osteopenia in the spinal hyperostotic mouse (twy/twy) in vivo
83. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine
84. Purification and characterization of acid phosphatase from yellow lupin (Lupinus luteus) seeds
85. Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta-1-stimulated chondrocytes and cartilage
86. Transforming growth factor beta increases ecto-nucleoside triphosphate pyrophosphatase activity of human bone-derived cells
87. 3, parathyroid hormone, and dexamethasone
88. Inorganic pyrophosphate gives a membrane potential in yeast mitochondria, as measured with the permeant cation tetraphenylphosphonium
89. Cartilage macromolecules and the calcification of cartilage matrix
90. Inorganic-pyrophosphate-dependent phosphorylation of spinach thylakoid proteins
91. Inorganic pyrophosphate metabolism in arthritis
92. +-translocating pyrophosphatases: A new category of ion translocase
93. Familial and clinical aspects of calcium pyrophosphate deposition disease
94. Mechanisms of action of bisphosphonates
95. Differential effects of aging on human chondrocyte responses to transforming growth factor beta: Increased pyrophosphate production and decreased cell proliferation
96. Retinoic acid stimulates pyrophosphate elaboration by cartilage and chondrocytes
97. Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes
98. Ageing increases growth factor-induced inorganic pyrophosphate elaboration by articular cartilage
99. Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone
100. The influence of orthophosphate on the renal handling of inorganic pyrophosphate in man and dog
101. The pharmacology of bisphosphonates and new insights into their mechanisms of action
102. Low levels of urinary inorganic pyrophosphate indicating systemic pyrophosphate deficiency in a boy with idiopathic infantile arterial calcification
103. i-generating nucleoside triphosphate pyrophosphohydrolase (NTPPPH) isozyme PC-1 in idiopathic infantile arterial calcification
104. Stimulation of cartilage inorganic pyrophosphate elaboration by ascorbate
105. Transduction mechanisms of porcine chondrocyte inorganic pyrophosphate elaboration
106. Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis
107. Synovial fluid ATP: A potential substrate for the production of inorganic pyrophosphate
108. Arthritis and ankylosis in twy mice with hereditary multiple osteochondral lesions: With special reference to calcium deposition
109. Germline deletion of the nucleoside triphosphate (NTPPPH) plasma cell membrane glycoprotein (PC-1) produces abnormal calcification of periarticular tissues
110. Molecular cloning and sequence of cDNA encoding the pyrophosphate-energized vacuolar membrane proton pump of Arabidopsis thaliana
111. Development of a turbidimetric assay to study the effect of urinary components on calcium oxalate precipitation
112. Biochemical and molecular identification of distinct forms of alkaline phosphodiesterase I expressed on the apical and basolateral plasma membrane surfaces of rat hepatocytes
113. Evolutionary aspects of inorganic pyrophosphatase
114. Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells
115. Clinical comparison of two tartar control dentifrices: A twelve-week study
116. Differential regulation of the expression of nucleotide pyrophosphatases/phosphodiesterases in rat liver
117. Growth-related expression of the ectonucleotide pyrophosphatase PC-1 in rat liver
118. Autotaxin, tumor motility-stimulating exophosphodiesterase
119. Parathyroid hormone-related protein is abundant in osteoarthritic cartilage, and the parathyroid hormone-related protein 1-173 isoform is selectively induced by transforming growth factor beta in articular chondrocytes and suppresses generation of extracellular inorganic pyrophosphate
120. Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes (MCT cells)
121. Synthesis of medium pyrophosphate by soluble mitochondrial F1 through dimethyl sulfoxide-water transitions
122. Uptake of inorganic pyrophosphate by Bacillus megaterium
123. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization
124. Alkaline phosphatase: Placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5′-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy
125. Relationship between pyrophosphate, amorphous calcium phosphate and other factors in the sequence of calcification in vivo
126. Molecular cloning and functional expression of cDNA encoding a mammalian inorganic pyrophosphatase
127. Bacillus subtilis ORF yybQ encodes a manganese-dependent inorganic pyrophosphatase with distinctive properties: The first of a new class of soluble pyrophosphatase?
128. Correlations of genotype and phenotype in hypophosphatasia